Phathom Pharmaceuticals, Inc.·4

May 31, 6:34 PM ET

Nabulsi Azmi 4

4 · Phathom Pharmaceuticals, Inc. · Filed May 31, 2024

Insider Transaction Report

Form 4
Period: 2024-05-31
Nabulsi Azmi
Chief Operating Officer
Transactions
  • Award

    Common Stoock

    2024-05-31+7,500249,567 total
Holdings
  • Common Stock

    (indirect: By Trust)
    785,700
  • Common Stock

    (indirect: By 401(k))
    3,578.93
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs") granted on May 31, 2024. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of December 18, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4